Research Advances in Pharmacotherapy for Alcoholism

  • Raye Z. Litten
  • John P. Allen
Part of the Drug and Alcohol Abuse Reviews book series (DAAR, volume 3)

Abstract

The past decade has witnessed a burgeoning of pharmacotherapy research directed toward the resolution of acute and chronic problems with alcohol. Because of the multifaceted nature of alcohol abuse and alcoholism, a correspondingly wide range of possible medications are being actively investigated, and several show promise in managing the diverse alcohol-related problems that present in clinical practice.(SeeLitten and Allen1for review.)

Keywords

Serotonin NMDA Propranolol Haloperidol Chlordiazepoxide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R. Z. Litten and J. P. Allen (1991) Pharmacotherapies for alcoholism: Promising agents and clinical issues.Alcohol. Clin. Exp. Res. 15620–633.PubMedCrossRefGoogle Scholar
  2. 2.
    M. Victor (1983) Diagnosis and treatment of alcohol withdrawal states.Pract. Gastroenterol.7, 6–15.Google Scholar
  3. 3.
    C. Naranjo and E. Sellers (1986) Clinical assessment and pharmacotherapy of the alcohol withdrawal syndrome, inRecent Developments in Alcoholism: Combined Alcohol and Drug Abuse Typologies of Alcoholics the Withdrawal Syndrome Renal and Electrolyte Consequences vol. 4. M. Galanter, ed. Plenum, New York, pp. 265–281.Google Scholar
  4. 4.
    T. McCown and G. Breese (1990) Multiple withdrawals from chronic ethanol “kindles” inferior collicular seizure activity: Evidence for kindling of seizures associated with alcoholism.Alcohol. Clin. Exp. Res.14,394–399.PubMedCrossRefGoogle Scholar
  5. 5.
    J. C. Ballenger and R. M. Post (1978) Kindling as a model for alcohol withdrawal syndromes.Br. J. Psychiatry133, 1–14.PubMedCrossRefGoogle Scholar
  6. 6.
    M. Linnoila, I. Mefford, D. Nutt, and B. Adinoff (1987) Alcohol withdrawal and noradrenergic function.Ann. Intern. Med. 107875–889.PubMedGoogle Scholar
  7. 7.
    M. Brown, R. Anton, R. Malcolm, and J. Ballenger (1988) Alcohol detoxification and withdrawal seizures: Clinical support for a kindling hypothesis.Biol. Psychiatry23, 507–514.PubMedCrossRefGoogle Scholar
  8. 8.
    B. Adinoff, G. Bone, and M. Linnoila (1988) Acute ethanol poisoning and the ethanol withdrawal syndrome.Merl. Toxicol.3, 172–196.Google Scholar
  9. 9.
    P. Hoffman, C. Rabe, K. Grant, P. Valverius, M. Hudspith, and B. Tabakoff (1990) Ethanol and the NMDA receptor.Alcohol7, 229–231.PubMedCrossRefGoogle Scholar
  10. 10.
    W. Thompson, A. Johnson, W. Maddrey, and Osler Medical Housestaff (1975) Diazepam and paraldehyde for treatment of severe delirium tremens.Ann. Intern. Med. 82175–180.PubMedGoogle Scholar
  11. 11.
    G. Moskowitz, T. Chalmers, H. Sacks, R. Fagerstrom, and H. Smith (1983) Deficiencies of clinical trials of alcohol withdrawal.Alcoho l. Clin. Exp. Res.7, 42–46.CrossRefGoogle Scholar
  12. 12.
    J. O’Brien, R. Meyer, and D. Thorns (1983) Double-blind comparison of lorazepam and diazepam in the treatment of the acute alcohol abstinence syndrome.Curr. Ther. Res.34 825–831.Google Scholar
  13. 13.
    J. Mendels, T. Wasserman, T. Michals, and E. Fine (1985) Halazepam in the management ofacutealcohol withdrawal syndrome.J. Clin. Psychiatry46 172–174.PubMedGoogle Scholar
  14. 14.
    P. Devenyi and M. Harrison (1985) Prevention of alcohol withdrawal seizures with oral diazepam loading.Can. Med. Assoc. J.132,798–800.PubMedGoogle Scholar
  15. 15.
    M. Ticku and K. Kulkarniz (1988) Molecular interactions of ethanol with GABAergic system and potential of 8015–4513 as an ethanol antagonist.Pharmacol. Biochem. Behay.30,501–510.CrossRefGoogle Scholar
  16. 16.
    D. Nutt, B. Adinoff, and M. Linnoila (1989) Benzodiazepines in the treatment of alcoholism, inRecent Developments in Alcoholism: Treatment Researchvol. 7. M. Galanter, ed. Plenum, New York, pp. 283–313.Google Scholar
  17. 17.
    H. Corrodi, K. Fuxe, P. Ledbruck, and L. Olson (1971) Minor tranquilizers, stress, and central catecholamine neurons.Brain Res. 291–16.PubMedCrossRefGoogle Scholar
  18. 18.
    S. Grant, Y. Huang, and D. Redmond (1980) Benzodiazepines attenuate single unit activity in the locus coeruleus.Life Sci. 272231–2236.PubMedCrossRefGoogle Scholar
  19. 19.
    I. Yoshishige, T. Masotoshi, A. Tsuda, S. Tsujimaru, and N. Nagasaki (1985) Attenuating effect of diazepam on stress induced in noradrenaline turnover in specific brain regions of Hats: Antagonism by Ro 15–1788.Life Sci. 372491–2498.CrossRefGoogle Scholar
  20. 20.
    A. Bizzi, M. Ricci, E. Veneroni, M. Amato, and S. Garattini (1984) Benzodiazepine receptor antagonists reverse the effect of diazepam on plasma corticosterone in stressed rat.J. Pharm. Pharmacol. 36134–135.PubMedCrossRefGoogle Scholar
  21. 21.
    P. Mormede, R. Dantzer, and A. Perio (1984) Relationship of the effects of the benzodiazepine derivative clorazepate on corticosterone secretion with its behavioural actions: Antagonism by RO 15–1788.Pharmacol. Biochem. Behay. 21839–843.CrossRefGoogle Scholar
  22. 22.
    J. Crawley, P. Ninan, D. Pickar, G. Chrousos, M. Linnoila, P. Skolnick, and S. Paul (1985) Neuropharmacological antagonism of the beta-carboline-induced “anxiety” response in rhesus monkeys.J. Neurosci. 5477–485.PubMedGoogle Scholar
  23. 23.
    A. Wilson and B. Vulcano (1985) Double-blind trial of alprazolam and chlordiazepoxide in the management of the acute ethanol withdrawal syndrome.Alcohol. Clin. Exp. Res. 923–27.PubMedCrossRefGoogle Scholar
  24. 24.
    E. Sellers, C. Naranjo, M. Harrison, P. Devenyl, C. Roach, and K. Sykora (1983) Diazepam loading: Simplified treatment of alcohol withdrawal.Clin. Pharmacol. Ther. 34822–826.PubMedCrossRefGoogle Scholar
  25. 25.
    A. Rosenbloom (1988) Emerging treatment options in the alcohol withdrawal syndrome.J. Clin. Psychiatry49 (Suppl. 12), 28–31.PubMedGoogle Scholar
  26. 26.
    K. George and J. Dundee (1977) Relative amnesic actions of diazepam, flunitrazepam, and lorazepam in man.Br. J. Clin. Pharmacol.4,45–50.PubMedCrossRefGoogle Scholar
  27. 27.
    J. Peachey and H. Annis (1984) Pharmacologic treatment of chronic alcoholism.Symp. Clin. Psychopharmacol. 117745–756.Google Scholar
  28. 28.
    R.G. Lister (1985) The amnesic action of benzodiazepines in man.Neurosci. Biobehay. Rev.9, 87–94.CrossRefGoogle Scholar
  29. 29.
    C. Schuster and R. Humphries (1981) Benzodiazepine dependencey in alcoholics.Conn. Med. 4511–13.PubMedGoogle Scholar
  30. 30.
    D. Zilm, E. Sellers, S. MacLeod, and N. Degani (1975) Propranolol effect on tremor in alcoholic withdrawal.Ann. Intern. Med. 83234–235.PubMedGoogle Scholar
  31. 31.
    D. Zilm, M. Jacob, S. MacLeod, E. Sellers, and T. Ti (1980) Propranolol and chlordiazepoxide effects on cardiac arrhythmeas during alcohol withdrawal.Alcohol Clin. Exp. Res.4,400–405.PubMedCrossRefGoogle Scholar
  32. 32.
    E. Sellers, D. Zilm, and N. Degani (1977) Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal.J. Stud. Alcohol 382096–2108.PubMedGoogle Scholar
  33. 33.
    M. Jacob, D. Zilm, S. MacLeod, and E. Sellers (1983) Propranolol-associated confused states during alcohol withdrawal.J. Clin. Psychopharmacol.3,185–187.PubMedCrossRefGoogle Scholar
  34. 34.
    M. Kraus, L. Gottlieb, R. Horwitz, and M. Anscher (1985) Randomized clinical trial of atenolol in patients with alcohol withdrawalN. Engl. J. Med.313,905–909.PubMedCrossRefGoogle Scholar
  35. 35.
    R. I. Horwitz, L. Gottlieb, and M. Kraus (1989) The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome.Arch. Intern. Med. 1491089–1093.PubMedCrossRefGoogle Scholar
  36. 36.
    P Cushman (1988) Clonidine and alcohol withdrawal.Adv. Alcohol Subst. Abuse7, 17–28.CrossRefGoogle Scholar
  37. 37.
    S. Bjorkqvist (1975) Clonidine in alcohol withdrawal.Acta Psychiatr. Scand. 52256–263.PubMedCrossRefGoogle Scholar
  38. 38.
    P. Cushman, R. Forbes, W. Lemer, and M. Stewart (1985) Alcohol withdrawal syndromes: Clinical management with lofexidine.Alcohol. Clin. Exp. Res. 9103–108.PubMedCrossRefGoogle Scholar
  39. 39.
    P Manhem, L. Nilsson, A. Moberg, J. Wadstein, and B. Hokfelt (1985) Alcohol withdrawal: Effects of clonidine treatment on sympathetic activity, the renin-aldosterone system, and clinical symptoms.Alcohol. Clin. Exp. Res. 9238–243.PubMedCrossRefGoogle Scholar
  40. 40.
    G. Baumgartnen and R. Rowen (1987) Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome.Arch. Intern. Med. 1471223–1226.CrossRefGoogle Scholar
  41. 41.
    P. Cushman and J. Sowers (1989) Alcohol withdrawal syndrome: Clinical and hormonal responses to alpha 2-adrenergic agonist treatment.Alcohol. Clin. Exp. Res.13, 361–364.PubMedCrossRefGoogle Scholar
  42. 42.
    B. Robinson, G. Robinson, T. Mating, T., and R. Johnson (1989) Is clonidine useful in the treatment of alcohol withdrawal.Alcohol. Clin. Exp. Res.13,95–98.Google Scholar
  43. 43.
    B. Liskow and D. Goodwin (1987) Pharmacological treatment of alcohol intoxication, withdrawal, and dependence: A critical review.J. Stud. Alcohol 48356–370.PubMedGoogle Scholar
  44. 44.
    J. Littleton (1989) Alcohol intoxication and physical dependence: A molecular mystery tour.Br. J. Addict.84, 267–276.PubMedCrossRefGoogle Scholar
  45. 45.
    S. Leslie, L. Brown, J. Dildy, and J. Sims (1990) Ethanol and neuronal calcium channels.Alcohol 7233–236.PubMedCrossRefGoogle Scholar
  46. 46.
    S. Dolin, H. Little, M. Hudspith, C. Pagonis, and J. Littleton (1987) Increased dihydropyridine-sensitive calcium channels in rat brain may underlie ethanol physical dependence.Neuropharmacology 26275–279.PubMedCrossRefGoogle Scholar
  47. 47.
    S. Dolin and H. Little (1989) Are changes in neuronal calcium channels involved in ethanol tolerance.J. Pharmacol. Exp. Ther. 250985–991.PubMedGoogle Scholar
  48. 48.
    H. Little, S. Dolin, and M. Halsey (1986) Calcium channel antagonists decrease the ethanol withdrawal syndrome.Life Sci. 392059–2065.PubMedCrossRefGoogle Scholar
  49. 49.
    J. Littleton, H. Little, and M. Whittington (1990) Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal: Doses required, stereospecificity and actions of Bay K 8644.Psychopharmacology 100387–392.PubMedCrossRefGoogle Scholar
  50. 50.
    P Wu, T. Pham, and C. Naranjo (1987) Nifedipine delays the acquisition of tolerance to ethanol.Eur. J. Pharmacol. 139233–236.PubMedCrossRefGoogle Scholar
  51. 51.
    J. Kril, A. Gundlach, P. Dodd, G. Johnston, and C. Harper (1989) Cortical dihydropyridine binding sites are unaltered in human alcoholic brain.Ann. Neurol. 26395–397.PubMedCrossRefGoogle Scholar
  52. 52.
    S. Marks, D. Watson, C. Carpenter, R. Messing, and D. Greenberg (1989) Calcium channel antagonist receptors in cerebral cortex from alcoholic patients.Brain Res.478, 196–198.PubMedCrossRefGoogle Scholar
  53. 53.
    S. Koppi, G. Eberhardt, R. Haller, and P. Konig (1987) Calcium-channelblocking agent in the treatment of acute alcohol withdrawal-caroverine versus meprobamate in a randomized double-blind study.Neuropsychobiology 1749–52.PubMedCrossRefGoogle Scholar
  54. 54.
    D. Butler and F. Messiha (1986) Alcohol withdrawal and carbamazepine.Alcohol3, 113–129.PubMedCrossRefGoogle Scholar
  55. 55.
    R. Malcolm, J. Ballenger, E. Sturgis, and R. Anton (1989) Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am.J. Psychiatr. 146617–621.PubMedGoogle Scholar
  56. 56.
    D. Gallant (1989) Improvements in treatment of alcohol withdrawal syndromes.Alcohol Clin. Exp. Res. 13721–722.Google Scholar
  57. 57.
    G. Young, C. Rores, C. Murphy, and R. Dailey (1987) Intravenous phenobarbital for alcohol withdrawal and convulsions.Ann. Emerg. Med. 16847–850.PubMedCrossRefGoogle Scholar
  58. 58.
    R. Simon (1988) Alcohol and SeizuresN. EngL J. Med. 319715,716.Google Scholar
  59. 59.
    E. Rothstein (1973) Prevention of alcohol withdrawal seizures: The roles of diphenylhydantoin and chlordiazepoxide.Am. J. Psychiatry 1301381–1382.PubMedGoogle Scholar
  60. 60.
    R. Sampliner and F. Iber (1974) Diphenylhydantoin control of alcohol withdrawal seizures.JAMA 2301430–1432.PubMedCrossRefGoogle Scholar
  61. 61.
    M. Palestine and E. Alatorre (1976) Control of acute alcoholic withdrawal symptoms: A comparative study of haloperidol and chlordiazepoxide.Curr. Ther. Res. 20289–299.PubMedGoogle Scholar
  62. 62.
    F. Lichtigfeld and M. Gillman (1982) The treatment of alcoholic withdrawal states with oxygen and nitrous oxide. S.Afr. Med. J. 61349–351.Google Scholar
  63. 63.
    N. Gillman and F. Lichtigfeld (1990) Analgesic nitrous oxide for alcohol withdrawal: A critical appraisal after 10 years’ use.Postgrad. Med J. 66543–546.PubMedCrossRefGoogle Scholar
  64. 64.
    K. Grant, P. Valverius, N. Hudspith, and B. Tabakoff (1990) Ethanol withdrawal seizures and the NMDA receptor complex.Eur. J. Pharmacol. 176289–296.PubMedCrossRefGoogle Scholar
  65. 65.
    R. Fuller, L. Branchey, D. Brightwell, R. Derman, C. Emrick, F. Iber, K. James, R. Lacoursiere, R. Lee, I. Lowenstam, I. Maany, D. Neiderhiser, J. Nocks, and S. Shaw (1986) Disulfiram treatment of alcoholism: A Veterans Administration Cooperative Study.JAMA 2561449–1455.PubMedCrossRefGoogle Scholar
  66. 66.
    G. Koob and F. Bloom (1988) Cellular and molecular mechanisms of drug dependence.Science 242715–723.PubMedCrossRefGoogle Scholar
  67. 67.
    W. McBride, J. M. Murphy, L. Lumeng, and T. Li (1990) Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats.Alcohol 7199–205.CrossRefGoogle Scholar
  68. 68.
    J. Ballenger, F. Goodwin, L. Major, and G. Brown (1979) Alcohol and central serotonin metabolism in man.Arch. Gen. Psychiatry 36224–227.PubMedCrossRefGoogle Scholar
  69. 69.
    S. Borg, H. Kvande, P. Liljeberg, D. Mossberg, and P. Valverius (1985) 5-Hydroxyindoleacetic acid in cerebrospinal fluid in alcoholic patients under different clinical conditions.Alcohol 2415–418.PubMedCrossRefGoogle Scholar
  70. 70.
    W. McBride, J. Murphy, L. Lumeng, and T. Li (1989) Serotonin and ethanol preference inRecent Developments in Alcoholism Treatment Research vol. 7. M. Galanter, ed. Plenum, New York, pp. 187–209.Google Scholar
  71. 71.
    K. Gill and Z. Amit (1989) Serotonin uptake blockers and voluntary alcohol consumption a review of recent studies, inRecent Developments in Alcoholism: Treatment Researchvol. 7. M. Galanter, ed. Plenum, New York, pp. 225–248.Google Scholar
  72. 72.
    D. Gorelick (1989) Serotonin uptake blockers and the treatment of alcoholism, inRecent Developments in Alcoholism: Treatment Researchvol. 7. M. Galanter, ed. Plenum, New York, pp. 267–281.Google Scholar
  73. 73.
    C. Naranjo, E. Sellers, C. Roach, D. Woodley, M. Sanchez-Craig, and K. Sykora (1984) Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers.Clin. Pharmacol. Ther. 35374–381.PubMedCrossRefGoogle Scholar
  74. 74.
    C. Naranjo, E. Sellers, J. Sullivan, D. Woodley, K. Kadlec, and K. Sykora (1987) The serotonin uptake inhibitor citalopram attenuates ethanol intake.Clin. Pharmacol. Ther. 41266–274.PubMedCrossRefGoogle Scholar
  75. 75.
    C. Naranjo, J. Sullivan, K. Kadlec, D. Woodley-Remus, R. Kennedy, and E. Sellers (1989) Differential effects of viqualine on alcohol intake and other consummatory behaviors.Clin. Pharmacol. Ther. 46301–309.PubMedCrossRefGoogle Scholar
  76. 76.
    C. Naranjo, K. Kadlec, P. Sanhueza, D. Woodley-Remus, and E. Sellers (1990) Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers.Clin. Pharmacol. Ther.47,490–498.PubMedCrossRefGoogle Scholar
  77. 77.
    Z. Amit, Z. Brown, A. Sutherland, G. Rockman, K. Gill, and N. Selvaggi (1985) Reduction in alcohol intake in humans as a function of treatment with zimelidine: Implications for treatment, inResearch Advances in New Psychopharmacological Treatments for Alcoholism. C. Naranjo and E. Sellers, eds. Excerpta Medica, Amsterdam, pp. 189–198.Google Scholar
  78. 78.
    J. Zabik and J. Roache (1983) 5-Hydroxytryptophan-induced conditioned taste aversion to ethanol in the rat.Pharmacol. Biochem. Behay. 18785–790.CrossRefGoogle Scholar
  79. 79.
    K. Gill, K. Shatz, Z. Amit, and S. Ogren (1986) Conditioned taste aversion to ethanol induced by zimelidine.Pharmacol. Biochem. Behay. 24463–468.CrossRefGoogle Scholar
  80. 80.
    H. Kranzier and D. Gorelick (1989) Serotonin uptake inhibitors: Pharmacotherapy for relapse prevention in alcoholics, inProceedings of the 35th International Congress on Alcoholism and Drug Dependence: Prevention and Control/Realities and Aspirationsvol. 2. R. Waahlberg, ed. National Directorate for the Prevention of Alcohol and Drug Problems, Norway, pp. 661–670.Google Scholar
  81. 81.
    M. Pottenger, M. McDernon, L. Patrie, M. Weissman, H. Ruben, and P. Newberry (1978) The frequency and persistence of depressive symptoms in the alcohol abuser.J. Nerv. Ment. Dis. 166562–570.PubMedCrossRefGoogle Scholar
  82. 82.
    G. Marlatt and J. Gordon (1980) Determinants of relapse: Implications for the maintenance of behavior change, inBehavioral Medicine: Changing Health Lifestyles. P. Davidson and S. Davidson, eds. Brunner/Mazel, New York, pp. 410–452.Google Scholar
  83. 83.
    P. Blier, C. DeMontigny, and Y. Chaput (1987) Modifications of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression.J. Clin. Psychopharmacol. 724S–35S.PubMedCrossRefGoogle Scholar
  84. 84.
    M. Goldman (1986) Neuropsychological recovery in alcoholics: Endogenous and exogenous processes.Alcohol. Clin. Exp. Res.10,136–144.PubMedCrossRefGoogle Scholar
  85. 85.
    I. Grant (1987) Alcohol and the brain: Neuropsychological correlates.J. Consult. Clin. Psychol. 55310–324.PubMedCrossRefGoogle Scholar
  86. 86.
    S. Gordon, B. Kennedy, and J. McPeake (1988) Neuropsychologically impaired alcoholics: Assessment, treatment considerations, and rehabilitation.J. Subst. Abuse Treat. 599–104.PubMedCrossRefGoogle Scholar
  87. 87.
    H. Weingartner, M. Buchsbaum, and M. Linnoila (1983) Zimelidine effects on memory impairments produced by ethanol.Life. Sci.33,2159–2163.PubMedCrossRefGoogle Scholar
  88. 88.
    P. Martin, B. Adinoff, M. Eckardt, J. Stapleton, G. Bone, D. Rubinow, E. Lane, and M. Linnoila (1989) Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine.Arch. Gen. Psychiatry 46617–621.PubMedCrossRefGoogle Scholar
  89. 89.
    G. Koob and F. Weiss (1990) Pharmacology of drug self-administration.Alcohol 7193–197.PubMedCrossRefGoogle Scholar
  90. 90.
    V. Borg (1983) Bromocriptine in the prevention of alcohol abuse.Acta. Psychiatr. Scand. 68100–110.PubMedCrossRefGoogle Scholar
  91. 91.
    M. Dongier and G. Schwartz (1989) The feasibility of effective psychopharmacological treatments for alcoholism.Br. J. Addict. 84227–228.PubMedCrossRefGoogle Scholar
  92. 92.
    K. Blum, A. Briggs, J. Wallace, C. Hall, and M. Trachtenberg (1987) Regional brain [Met]-enkephalin in alcohol-preferring and non-alcohol-preferring inbred stains of mice.Experientia 43408–410.PubMedCrossRefGoogle Scholar
  93. 93.
    A. Ho and N. Rossi (1982) Suppression of ethanol consumption by METenkephalin in rats.J. Pharm. Pharmacol. 34118–119.PubMedCrossRefGoogle Scholar
  94. 94.
    C. Hubbell, S. Czirr, G. Hunter, C. Beaman, N. LeCann, and L. Reid (1986) Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations.Alcohol 339–54.PubMedCrossRefGoogle Scholar
  95. 95.
    J. Froehlich and T. Li. (1990) Enkephalinergic involvement in voluntary drinking of alcohol, inOpioids Bulimia and Alcohol Abuse and Alcoholism. L. Reid, ed. Springer-Verlag, New York, pp. 217–228.Google Scholar
  96. 96.
    C. Gianoulakis, P. Angelogianni, M. Meaney, J. Thavundayil, and V. Tawar (1990) Endorphins in individuals with high and low risk for development of alcoholism, inOpioids Bulimia and Alcohol Abuse and Alcoholism. L. Reid ed. Springer-Verlag, New York, pp. 229–246.Google Scholar
  97. 97.
    R. Myers, S. Borg, and R. Mossberg (1986) Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey.Alcohol 3383–388.PubMedCrossRefGoogle Scholar
  98. 98.
    J. Volpicelli, M. Davis, and J. Olgin (1986) Naltrexone blocks the post-shock increase of ethanol consumption.Life Sci. 38841–847.PubMedCrossRefGoogle Scholar
  99. 99.
    J. Volpicelli, C. O’Brien, A. Alterman, and M. Hayashida (1990) Naltrexone and the treatment of alcohol-dependence: Initial observations, inOpioids Bulimia and Alcohol Abuse and Alcoholism L. Reid ed. Springer-Verlag, New York, pp. 195–214.Google Scholar
  100. 100.
    S.O’Malley, A. Jaffe, G. Chang, G. Witte, R. Schottenfeld, and B. Rounsaville. Naltrexone in the treatment of alcohol dependence: Preliminary findings, inNovel Pharmacological Interventions for Alcoholism.C. Naranjo and E. Sellers, eds. Springer-Verlag, New York, in press.Google Scholar
  101. 101.
    S. O’Malley, A. Jaffe, R. Schottenfeld, and B. Rounsaville (1991) Naltrexone and coping skills therapy in the treatment of alcohol dependence.Alcohol. Clin. Exp. Res. 15382.Google Scholar
  102. 102.
    M. Fantino, J. Hosotte, and M. Apfelbaum (1986) An opioid antagonist, naltrexone, reduces preference for sucrose in humans. Am.J. Physiol. 251R91–R96.PubMedGoogle Scholar
  103. 103.
    T Kirkham and J. Blundell (1987) Effects of naloxone and naltrexone on meal patterns of freely-feeding rats.Pharmacol. Biochem. Behay. 26515–520.CrossRefGoogle Scholar
  104. 104.
    M. Manila, R. Aranko, and T. Seppala (1982) Acute effects of buspirone and alcohol on psychomotor skills.J. Clin. Psychiatry 4356–60.Google Scholar
  105. 105.
    D. Taylor, M. Eison, L. Riblet, and C. Vandermaelen (1985) Pharmacological and clinical effects of buspirone.Pharmacol. Biochem. Behay. 23687–694.CrossRefGoogle Scholar
  106. 106.
    A. Eison and D. Temple (1986) Buspirone: Review of its pharmacology and current perspectives on its mechanism actionAnt. J. Med80 (Suppl. 3B), 1–9.CrossRefGoogle Scholar
  107. 107.
    A. Smiley and H. Moskowitz (1986) Effects of long-term administration of buspirone and diazepam on driver steering control.Am. J. Med. 80 (Suppl. 3B), 22–29.PubMedCrossRefGoogle Scholar
  108. 108.
    D. Collins and R. Myers (1987) Buspirone attenuates volitional alcohol intake in the chronically drinking monkey.Alcohol 4456.CrossRefGoogle Scholar
  109. 109.
    T. Privette, R. Hornsby, and R. Myers (1988) Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways.Alcohol 5147–152.PubMedCrossRefGoogle Scholar
  110. 110.
    F. Bruno (1989) Buspirone in the treatment of alcoholic patients.Psychopathology22,49–59.PubMedCrossRefGoogle Scholar
  111. 111.
    H. Kranzler and R. Meyer (1989) An open trial of buspirone in alcoholics.J. Clin. Psychopharmacol. 9379–380.PubMedCrossRefGoogle Scholar
  112. 112.
    B. Hwang, L. Lumeng, J. Wu, and T. Li (1990) Increased number of GAB Aergic terminals in the nucleus accumbens is associated with alcohol preference in rats.Alcohol Clin. Exp. Res. 14503–507.PubMedCrossRefGoogle Scholar
  113. 113.
    H.Samson, G. Tolliver, A. Pfeffer, R. Sadeghi, and K. Mills (1987) Oral ethanol reinforcement in the rat: Effect of the partial inverse benzodiazepine agonist RO 15–4513.Pharmacol. Biochem. Behay.27,517–519.CrossRefGoogle Scholar
  114. 114.
    R. Lister and D. Nutt (1987) Is RO 15–4513 a specific alcohol antagonist?Trends Neurosci. 10223–225.CrossRefGoogle Scholar
  115. 115.
    K. Britton, C. Ehlers, and G. Koob (1988) Is ethanol antagonist 80154513 selective for ethanol?Science239, 648–649.PubMedCrossRefGoogle Scholar
  116. 116.
    J. Lhuintre, M. Daoust, N. Moore, P. Chretien, C. Saligaut, G. Tran, F. Boismare, and B. Hillemand (1985) Ability of calciumbisacetyl homotaurine, a GABA agonist to prevent relapse in weaned alcoholics.Lancet 11014–1016.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Raye Z. Litten
  • John P. Allen

There are no affiliations available

Personalised recommendations